BG
OM icon

Bellevue Group’s Outset Medical OM Stock Holding History

Bellevue Group’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,853
Closed -$2.94M – 172
2024
Q2 		$2.94M Buy
50,853
+12,696
+33% +$622K 0.05% 106
2024
Q1 		$1.27M Sell
38,157
-79,185
-67% -$4.01M 0.02% 116
2023
Q4 		$9.52M Sell
117,342
-43,220
-27% -$3.52M 0.15% 87
2023
Q3 		$26.2M Sell
160,562
-47,830
-23% -$11.3M 0.42% 67
2023
Q2 		$68.4M Buy
208,392
+14,608
+8% +$4.46M 0.98% 31
2023
Q1 		$53.5M Buy
193,784
+4,205
+2% +$1.54M 0.78% 46
2022
Q4 		$73.4M Buy
189,579
+28,415
+18% +$8.01M 0.97% 32
2022
Q3 		$38.5M Buy
161,164
+6,049
+4% +$1.62M 0.55% 54
2022
Q2 		$34.6M Buy
155,115
+20,638
+15% +$8.88M 0.49% 60
2022
Q1 		$91.6M Buy
134,477
+97,103
+260% +$58.4M 1.06% 32
2021
Q4 		$25.8M Buy
37,374
+6,903
+23% +$5.1M 0.27% 94
2021
Q3 		$22.6M Hold
30,471
– – 0.23% 100
2021
Q2 		$22.8M Buy
30,471
+13,423
+79% +$10.3M 0.22% 104
2021
Q1 		$13.9M Buy
17,048
+4,401
+35% +$3.4M 0.15% 112
2020
Q4 		$10.8M Buy
12,647
+7,319
+137% +$5.64M 0.12% 115
2020
Q3 		$4M Buy
+5,328
New +$4.38M 0.06% 129

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $34.8B AUM 107.63% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Bellevue Group's OM Position: Q3 2024 in Review

Bellevue Group sold out of Outset Medical (OM) in Q3 2024, closing a stake of 50,853 shares — an estimated $2.94M sold.

Bellevue Group first reported a position in OM in Q3 2020 and held it in 16 quarters. The position peaked at $91.6M in Q1 2022. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

  • Bellevue Group reported no remaining Outset Medical position as of Q3 2024 after selling out during the quarter.
  • Bellevue Group sold 50,853 Outset Medical shares in Q3 2024, an estimated $2.94M.
  • Bellevue Group first reported a position in Outset Medical in Q3 2020 and held it in 16 quarters.
  • Bellevue Group's Outset Medical position peaked at $91.6M in Q1 2022.
  • 78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on Bellevue Group's 13F filing for Q3 2024, filed 14 Nov 2024.